在重症患者的连续置换疗法中使用纳法莫斯塔特甲基酸盐剂量:一项两中心观察性研究
Shinya Kameda1, Akinori Maeda2, Shun Maeda3
1Intensive Care Unit, The Jikei University Hospital, 3-19-18 Nishi-Shimbashi, Minato-ku, 105-8471, Tokyo, Japan. shinyakameda0925.tt@gmail.com.
BMC nephrology
|February 26, 2024
概括
在重症患者的连续脏替代疗法 (CKRT) 中,纳法莫斯塔特甲基酸盐剂量没有显著影响过器寿命. 需要进一步的随机试验来确定最佳剂量,以安全地防止过器凝血.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 纳法莫斯塔特酸盐是一种抗凝剂,用于重症患者的连续置换疗法 (CKRT).
- 它的短半衰期需要了解最佳剂量以有效使用.
- 目前在CKRT期间纳法莫斯塔特甲基酸盐的最佳剂量仍未确定.
研究的目的:
- 为了研究在CKRT期间纳法莫斯塔特甲基酸盐的最佳剂量.
- 为了探索纳法莫斯塔特甲酸盐剂量与过器寿命之间的关系.
- 评估与CKRT中纳法莫斯塔特甲基酸盐使用相关的安全性和临床结果.
主要方法:
- 一项两中心的观察性研究包括在CKRT期间接受纳法莫斯塔特甲基酸盐的严重病情的成年患者.
- 过器寿命,定义为过凝血的时间,是主要结果.
- 考克斯的比例危险模型被用于过透度的生存分析,调整为出血风险和血过.
主要成果:
- 这项研究包括269名患者.
- 纳法莫斯塔特甲基酸盐的平均剂量为15.8毫克/小时,过器的平均寿命为18.3小时.
- 在调整后,没有发现纳法莫斯塔特甲基酸盐剂量与波器寿命 (HR 1.12; p=0.60) 之间有显著的关联.
结论:
- 在CKRT患者中,没有观察到纳法莫斯塔特甲基酸盐剂量 (5-30 mg/h) 和过器寿命之间的剂量反应关系.
- 需要进行进一步的随机对照试验,以确定最佳剂量,以安全地预防过器凝血.
- 目前的证据不支持为最大限度地提高过器寿命的特定剂量.
更多相关视频
相关概念视频
01:11Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
01:27Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
01:17Factors Affecting Renal Clearance: Renal Impairment
94
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
94
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
01:22Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K